Pharmaceuticals Top 5 Emerging Markets Industry Guide 2017

Date: May 31, 2017
Pages: 140
Price:
US$ 995.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PC17C247C3EEN
Leaflet:

Download PDF Leaflet

Pharmaceuticals Top 5 Emerging Markets Industry Guide 2017
Pharmaceuticals Top 5 Emerging Markets Industry Guide 2017

SUMMARY

The Emerging 5 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

SYNOPSIS

Essential resource for top-line data and analysis covering the emerging five pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

KEY HIGHLIGHTS
  • These countries contributed $168.1 billion to the global pharmaceuticals industry in 2016, with a compound annual growth rate (CAGR) of 11.8% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $267.5 billion in 2021, with a CAGR of 9.7% over the 2016-21 period.
  • Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $99.4 billion in 2016. This was followed by India and Mexico with a value of $29.4 and $19.9 billion, respectively.
  • China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $155.8 billion in 2021, followed by India and Mexico with expected values of $59.1 and $25.6 billion, respectively.
SCOPE
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ emerging five operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with five year forecasts
  • Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
REASONS TO BUY
  • What was the size of the emerging five pharmaceuticals market by value in 2016?
  • What will be the size of the emerging five pharmaceuticals market in 2021?
  • What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the emerging five pharmaceuticals market?
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Top Emerging Countries Pharmaceuticals
Industry Outlook
Pharmaceuticals in South Africa
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Brazil
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in India
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Mexico
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading companies
Appendix
Methodology
About MarketLine

LIST OF TABLES

Table 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2012-21
Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2012-16
Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2016-21
Table 4: South Africa pharmaceuticals market value: $ billion, 2012–16
Table 5: South Africa pharmaceuticals market geography segmentation: $ billion, 2016
Table 6: South Africa pharmaceuticals market share: % share, by value, 2016
Table 7: South Africa pharmaceuticals market value forecast: $ billion, 2016–21
Table 8: South Africa size of population (million), 2012–16
Table 9: South Africa gdp (constant 2005 prices, $ billion), 2012–16
Table 10: South Africa gdp (current prices, $ billion), 2012–16
Table 11: South Africa inflation, 2012–16
Table 12: South Africa consumer price index (absolute), 2012–16
Table 13: South Africa exchange rate, 2012–16
Table 14: Brazil pharmaceuticals market value: $ billion, 2012–16
Table 15: Brazil pharmaceuticals market geography segmentation: $ billion, 2016
Table 16: Brazil pharmaceuticals market share: % share, by value, 2016
Table 17: Brazil pharmaceuticals market value forecast: $ billion, 2016–21
Table 18: Brazil size of population (million), 2012–16
Table 19: Brazil gdp (constant 2005 prices, $ billion), 2012–16
Table 20: Brazil gdp (current prices, $ billion), 2012–16
Table 21: Brazil inflation, 2012–16
Table 22: Brazil consumer price index (absolute), 2012–16
Table 23: Brazil exchange rate, 2012–16
Table 24: China pharmaceuticals market value: $ billion, 2012–16
Table 25: China pharmaceuticals market geography segmentation: $ billion, 2016
Table 26: China pharmaceuticals market share: % share, by value, 2016
Table 27: China pharmaceuticals market value forecast: $ billion, 2016–21
Table 28: China size of population (million), 2012–16
Table 29: China gdp (constant 2005 prices, $ billion), 2012–16
Table 30: China gdp (current prices, $ billion), 2012–16
Table 31: China inflation, 2012–16
Table 32: China consumer price index (absolute), 2012–16
Table 33: China exchange rate, 2012–16
Table 34: India pharmaceuticals market value: $ billion, 2012–16
Table 35: India pharmaceuticals market geography segmentation: $ billion, 2016
Table 36: India pharmaceuticals market share: % share, by value, 2016
Table 37: India pharmaceuticals market value forecast: $ billion, 2016–21
Table 38: India size of population (million), 2012–16
Table 39: India gdp (constant 2005 prices, $ billion), 2012–16
Table 40: India gdp (current prices, $ billion), 2012–16
Table 41: India inflation, 2012–16
Table 42: India consumer price index (absolute), 2012–16
Table 43: India exchange rate, 2012–16
Table 44: Mexico pharmaceuticals market value: $ billion, 2012–16
Table 45: Mexico pharmaceuticals market geography segmentation: $ billion, 2016
Table 46: Mexico pharmaceuticals market share: % share, by value, 2016
Table 47: Mexico pharmaceuticals market value forecast: $ billion, 2016–21
Table 48: Mexico size of population (million), 2012–16
Table 49: Mexico gdp (constant 2005 prices, $ billion), 2012–16
Table 50: Mexico gdp (current prices, $ billion), 2012–16
Table 51: Mexico inflation, 2012–16
Table 52: Mexico consumer price index (absolute), 2012–16
Table 53: Mexico exchange rate, 2012–16
Table 54: Adcock Ingram Holdings Limited: key facts
Table 55: Adcock Ingram Holdings Limited: key financials ($)
Table 56: Adcock Ingram Holdings Limited: key financials (ZAR)
Table 57: Adcock Ingram Holdings Limited: key financial ratios
Table 58: Aspen Pharmacare Holdings Ltd: key facts
Table 59: Aspen Pharmacare Holdings Ltd: key financials ($)
Table 60: Aspen Pharmacare Holdings Ltd: key financials (ZAR)
Table 61: Aspen Pharmacare Holdings Ltd: key financial ratios
Table 62: Novartis AG: key facts
Table 63: Novartis AG: key financials ($)
Table 64: Novartis AG: key financial ratios
Table 65: Sanofi SA: key facts
Table 66: Sanofi SA: key financials ($)
Table 67: Sanofi SA: key financials (€)
Table 68: Sanofi SA: key financial ratios
Table 69: Aché Laboratórios Farmacêuticos S.A.: key facts
Table 70: EMS SA: key facts
Table 71: Guangzhou Pharmaceutical Holdings Limited: key facts
Table 72: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 73: Shanghai Pharmaceuticals Holding Co Ltd: key financials ($)
Table 74: Shanghai Pharmaceuticals Holding Co Ltd: key financials (CNY)
Table 75: Shanghai Pharmaceuticals Holding Co Ltd: key financial ratios
Table 76: Yangtze River Pharmaceutical Group: key facts
Table 77: Yunnan Baiyao Group Co., Ltd.: key facts
Table 78: Yunnan Baiyao Group Co., Ltd.: key financials ($)
Table 79: Yunnan Baiyao Group Co., Ltd.: key financials (CNY)
Table 80: Yunnan Baiyao Group Co., Ltd.: key financial ratios
Table 81: Aurobindo Pharma Limited: key facts
Table 82: Aurobindo Pharma Limited: key financials ($)
Table 83: Aurobindo Pharma Limited: key financials (Rs.)
Table 84: Aurobindo Pharma Limited: key financial ratios
Table 85: Lupin Limited: key facts
Table 86: Lupin Limited: key financials ($)
Table 87: Lupin Limited: key financials (Rs.)
Table 88: Lupin Limited: key financial ratios
Table 89: Dr. Reddy's Laboratories Limited: key facts
Table 90: Dr. Reddy's Laboratories Limited: key financials ($)
Table 91: Dr. Reddy's Laboratories Limited: key financials (Rs.)
Table 92: Dr. Reddy's Laboratories Limited: key financial ratios
Table 93: Sun Pharmaceutical Industries Ltd.: key facts
Table 94: Sun Pharmaceutical Industries Ltd.: key financials ($)
Table 95: Sun Pharmaceutical Industries Ltd.: key financials (Rs.)
Table 96: Sun Pharmaceutical Industries Ltd.: key financial ratios
Table 97: Bayer AG: key facts
Table 98: Bayer AG: key financials ($)
Table 99: Bayer AG: key financials (€)
Table 100: Bayer AG: key financial ratios
Table 101: Merck & Co., Inc.: key facts
Table 102: Merck & Co., Inc.: key financials ($)
Table 103: Merck & Co., Inc.: key financial ratios
Table 104: Pfizer Inc.: key facts
Table 105: Pfizer Inc.: key financials ($)
Table 106: Pfizer Inc.: key financial ratios

LIST OF FIGURES

Figure 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2012-21
Figure 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2012-16
Figure 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2016-21
Figure 4: South Africa pharmaceuticals market value: $ billion, 2012–16
Figure 5: South Africa pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 6: South Africa pharmaceuticals market share: % share, by value, 2016
Figure 7: South Africa pharmaceuticals market value forecast: $ billion, 2016–21
Figure 8: Forces driving competition in the pharmaceuticals market in South Africa, 2016
Figure 9: Drivers of buyer power in the pharmaceuticals market in South Africa, 2016
Figure 10: Drivers of supplier power in the pharmaceuticals market in South Africa, 2016
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2016
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2016
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2016
Figure 14: Brazil pharmaceuticals market value: $ billion, 2012–16
Figure 15: Brazil pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 16: Brazil pharmaceuticals market share: % share, by value, 2016
Figure 17: Brazil pharmaceuticals market value forecast: $ billion, 2016–21
Figure 18: Forces driving competition in the pharmaceuticals market in Brazil, 2016
Figure 19: Drivers of buyer power in the pharmaceuticals market in Brazil, 2016
Figure 20: Drivers of supplier power in the pharmaceuticals market in Brazil, 2016
Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2016
Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2016
Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2016
Figure 24: China pharmaceuticals market value: $ billion, 2012–16
Figure 25: China pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 26: China pharmaceuticals market share: % share, by value, 2016
Figure 27: China pharmaceuticals market value forecast: $ billion, 2016–21
Figure 28: Forces driving competition in the pharmaceuticals market in China, 2016
Figure 29: Drivers of buyer power in the pharmaceuticals market in China, 2016
Figure 30: Drivers of supplier power in the pharmaceuticals market in China, 2016
Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2016
Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2016
Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in China, 2016
Figure 34: India pharmaceuticals market value: $ billion, 2012–16
Figure 35: India pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 36: India pharmaceuticals market share: % share, by value, 2016
Figure 37: India pharmaceuticals market value forecast: $ billion, 2016–21
Figure 38: Forces driving competition in the pharmaceuticals market in India, 2016
Figure 39: Drivers of buyer power in the pharmaceuticals market in India, 2016
Figure 40: Drivers of supplier power in the pharmaceuticals market in India, 2016
Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2016
Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2016
Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in India, 2016
Figure 44: Mexico pharmaceuticals market value: $ billion, 2012–16
Figure 45: Mexico pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 46: Mexico pharmaceuticals market share: % share, by value, 2016
Figure 47: Mexico pharmaceuticals market value forecast: $ billion, 2016–21
Figure 48: Forces driving competition in the pharmaceuticals market in Mexico, 2016
Figure 49: Drivers of buyer power in the pharmaceuticals market in Mexico, 2016
Figure 50: Drivers of supplier power in the pharmaceuticals market in Mexico, 2016
Figure 51: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2016
Figure 52: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2016
Figure 53: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2016
Figure 54: Adcock Ingram Holdings Limited: revenues & profitability
Figure 55: Adcock Ingram Holdings Limited: assets & liabilities
Figure 56: Aspen Pharmacare Holdings Ltd: revenues & profitability
Figure 57: Aspen Pharmacare Holdings Ltd: assets & liabilities
Figure 58: Novartis AG: revenues & profitability
Figure 59: Novartis AG: assets & liabilities
Figure 60: Sanofi SA: revenues & profitability
Figure 61: Sanofi SA: assets & liabilities
Figure 62: Shanghai Pharmaceuticals Holding Co Ltd: revenues & profitability
Figure 63: Shanghai Pharmaceuticals Holding Co Ltd: assets & liabilities
Figure 64: Yunnan Baiyao Group Co., Ltd.: revenues & profitability
Figure 65: Yunnan Baiyao Group Co., Ltd.: assets & liabilities
Figure 66: Aurobindo Pharma Limited: revenues & profitability
Figure 67: Aurobindo Pharma Limited: assets & liabilities
Figure 68: Lupin Limited: revenues & profitability
Figure 69: Lupin Limited: assets & liabilities
Figure 70: Dr. Reddy's Laboratories Limited: revenues & profitability
Figure 71: Dr. Reddy's Laboratories Limited: assets & liabilities
Figure 72: Sun Pharmaceutical Industries Ltd.: revenues & profitability
Figure 73: Sun Pharmaceutical Industries Ltd.: assets & liabilities
Figure 74: Bayer AG: revenues & profitability
Figure 75: Bayer AG: assets & liabilities
Figure 76: Merck & Co., Inc.: revenues & profitability
Figure 77: Merck & Co., Inc.: assets & liabilities
Figure 78: Pfizer Inc.: revenues & profitability
Figure 79: Pfizer Inc.: assets & liabilities
Skip to top


Haircare Top 5 Emerging Markets Industry Guide 2016 US$ 995.00 Jul, 2016 · 133 pages
New Cars Top 5 Emerging Markets Industry Guide 2016 US$ 995.00 Jul, 2016 · 134 pages
Airlines Top 5 Emerging Markets Industry Guide 2017 US$ 995.00 Jun, 2017 · 154 pages

Ask Your Question

Pharmaceuticals Top 5 Emerging Markets Industry Guide 2017
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: